ライフサイエンスコーパス: MIC

1 MIC digestion allowed the decomposition of up to 500 mg

2 MIC frequency, mode, and geometric mean were calculated

3 MIC results for 115 Staphylococcus intermedius group iso

4 MIC testing revealed that 517/993 (52.1%) isolates were

5 MIC(X1; X2; Y) is employed to detect pair-wise synergy i

6 MICs falsely elevated above the resistance breakpoint we

7 MICs for penicillin and erythromycin were correlated (P

8 MICs possess advantageous traits that may originate in t

9 MICs were determined via broth microdilution.

10 ch surgeon performing at least 10 OCs and 10 MICs.

11 The antibiotics at the concentration of 1x MIC induced obvious morphological changes in susceptible

12 ociated with maximal Mtb kill was an AUC0-24/MIC of 23.37 +/- 1.16.

13 d moxifloxacin exposure targets were AUC0-24/MIC ratios of 62 and 122, and a faropenem percentage of

14 s, each child will achieve different AUC0-24/MIC ratios when treated with the same dose.

15 We identified the linezolid AUC0-24/MIC target for optimal efficacy against pediatric intrac

16 0-24), maximum concentration (Cmax), AUC0-24/MIC, Cmax/MIC, and percentage of time that concentration

17 No dose-limiting cytotoxicity at >/=2x MIC or hemolysis at >/=8x MIC was observed.

18 A similar meta-analysis comparing 517 MIC values from different bacterial genera (Bacillus, Cu

19 otoxicity at >/=2x MIC or hemolysis at >/=8x MIC was observed.

20 8-fold increase in oxacillin potency, for a MIC of 16 mug mL(-1).

21 n vitro activity against H. pylori, having a MIC value of 4 mug/mL.

22 of a U=C donor-acceptor bond, composed of a MIC-->U sigma-component and a U(5f)-->MIC(2p) pi-back-bo

23 mising antibiotic activity against Mm with a MIC of 0.21 muM and showed up to 89% reduction of Lp gro

24 high antibiotic activity against Ef, with a MIC of 0.57 muM.

25 22, and a faropenem percentage of time above MIC >60%, in combination therapy.

26 tures and empirically-determined activities (MICs, IC50, etc.) against more than 4200 specific target

27 owed moderate to good inhibitory activities (MICs=62.5-125mug/ml) against three bacteria, as well as

28 seudomonas aeruginosa Gram-negative activity MIC's of 4.2-21.6 muM.

29 Gepotidacin AD MIC levels were increased and disk zone diameters were d

30 Although MIC(X 1; X 2; Y) can capture a wide range of interaction

31 er, the moderate correlation of amphotericin MICs with zone diameters (-0.42) precludes the use of am

32 For amphotericin B, an MIC of </=0.5 mug/ml was significantly associated with b

33 VGS from 15.6% and 16.7% of patients had an MIC >2 mug/mL, respectively.

34 er T2 VGS from 6.1% and 6.3% patients had an MIC >2 mug/mL.

35 between azithromycin exposure </=30 days and MIC (beta, 1.00; 95% confidence interval, 0.44-1.56; P =

36 between azithromycin exposure </=30 days and MIC (beta: 1.00, 95%-CI: 0.44-1.56, p=0.002).

37 All disk diffusion and MIC QC ranges established in this study were approved by

38 Disk diffusion and MIC quality control (QC) ranges were determined for nafi

39 as performed to establish disk diffusion and MIC ranges for cefepime-tazobactam for multiple QC refer

40 The disk and MIC breakpoints evaluated included the Clinical and Labo

41 illin MIC breakpoints and cefoxitin disk and MIC breakpoints, the CLSI M100-S25 coagulase-negative St

42 Oxacillin and cefoxitin disk and MIC tests were evaluated for the detection of mecA- or m

43 esults interpreted by the VET01-S2 (disk and MIC) and M100-S25 CoNS (MIC) breakpoints agreed with the

44 e best inhibitors have enzyme inhibition and MIC values near or below that of trimethoprim against wi

45 Nucleosome occupancy in MAC and MIC are nonetheless highly correlated with each other, a

46 Bedaquiline DST methodologies and MIC QC ranges against the H37Rv M. tuberculosis referenc

47 d, the mean change in ranking between OC and MIC was 25 positions.

48 tual information), doublets (gene pairs) and MIC(X 1; X 2; Y) based on the maximal information coeffi

49 activity was evaluated by the hole plate and MIC techniques and the antimutagenic activity was evalua

50 s observed for results by pyrohydrolysis and MIC methods showing the feasibility of the proposed meth

51 killing both the bulk of melanoma cells and MICs.

52 r the presence of interesting antibacterial [MIC(S. pneumoniae) approximately 1.2 muM] and anticancer

53 -resistant S. aureus strain with appreciable MIC values.

54 erentiation factor 15 (GDF15), also known as MIC-1, is a distant member of the transforming growth fa

55 reference feature selection methods such as MIC(X; Y) and TSG.

56 ug and between-child variability, as well as MIC distribution, were used, and the cumulative fraction

57 ntration (MIC) >/=0.06 mg/L and azithromycin MIC >/=0.5 mg/L, of which 3 (30%) had DNA detected at da

58 Mean azithromycin MIC was 0.28 mg/L (range, <0.016-24 mg/L).

59 Mean azithromycin MIC was 0.28 mg/L (range: <0.016-24 mg/L).

60 ates with lower ceftriaxone and azithromycin MICs, only 13 (7%) had persistent DNA (odds ratio, 5.8 [

61 All isolates had azithromycin MICs >16 microg/mL and 5 had ceftriaxone MICs = 0.125 mi

62 s known to cause azole resistance, and azole MICs are reported here.

63 sion of carRS and almEFG and the polymyxin B MIC increased in mutants lacking toxRS or leuO Conversel

64 euO overexpression decreased the polymyxin B MIC.

65 Bedaquiline MIC frequency, mode, and geometric mean were calculated.

66 equivalence was demonstrated for bedaquiline MICs determined using 7H10 agar and 7H11 agar but not fo

67 0 agar and 7H11 agar but not for bedaquiline MICs determined using 7H9 broth and 7H10 agar or 7H9 bro

68 , with one data set excluded) of bedaquiline MICs.

69 (7H11 agar dilution; 232/242) of bedaquiline MICs.

70 Unprecedented f-block MIC complexes [M(N'')3 {CN(Me)C(Me)N(Me)CH}] (M=U, Y, La

71 se and obscurin) was dramatically altered by MIC, and we propose ways these kinases could play a fund

72 % and the results after digestion of CRMs by MIC were in agreement better than 95% to certified value

73 fluenzae, and 5 Escherichia coli isolates by MIC and 30 S. aureus, 15 S. pneumoniae, and 15 S. pyogen

74 s of which 663 were found to be regulated by MIC.

75 owed the lowest minimum inhibitory capacity (MIC); therefore presenting higher antibacterial effect.

76 Neutral mesoionic carbenes (MICs) have emerged as an important class of carbene, how

77 framework flanked by two mesoionic carbenes (MICs).

78 Caspofungin MICs were also determined using the commercially availab

79 ei isolates, as all isolates had caspofungin MICs above the threshold for resistance measured using t

80 All C. glabrata isolates had caspofungin MICs of >/=0.5 mug/ml, the clinical breakpoint for caspo

81 polystyrene microtiter trays on caspofungin MICs using 209 isolates of four Candida species, includi

82 tant/non-wild-type isolates when caspofungin MICs were measured using untreated polystyrene trays and

83 as susceptible or resistant when caspofungin MICs were measured with treated or untreated trays and w

84 ed clinical laboratories to support cefepime MIC-based dosing strategies.

85 lity to treat strains with elevated cefepime MICs is codified in new susceptible dose-dependent (SDD)

86 (MICs) >256 mug/mL and elevated ceftriaxone MICs (>/=0.125 mug/mL).

87 cin MICs >16 microg/mL and 5 had ceftriaxone MICs = 0.125 microg/mL by agar dilution.

88 e population of metastasis-initiating cells (MICs).

89 endent hydrophobicity from positive centers (MIC = 1-4 mug/mL and HC50 = 60-65 mug/mL), molecules wit

90 ligands, that is, MHC class I-related chain (MIC) A/B and UL16-binding proteins (ULBP)1-6 (NKG2D liga

91 were analyzed; 2 were nonsusceptible to CHG (MICs, 8 mug/ml), and 5/814 (0.6%) carried qacA or qacB A

92 A (M-CAD) and Microfluidic In-vitro Cloning (MIC) and applied them to de novo synthesis, combinatoria

93 imum concentration (Cmax), AUC0-24/MIC, Cmax/MIC, and percentage of time that concentrations persiste

94 iazid Cmax was <4.6 mg/L and rifampicin Cmax/MIC <28, the isoniazid concentration had an antagonistic

95 s between isoniazid Cmax and rifampicin Cmax/MIC ratio on 2-month culture conversion.

96 dentified isoniazid Cmax and rifampicin Cmax/MIC thresholds below which there is concentration-depend

97 sed a novel maximal information coefficient (MIC) measure to capture a wide range of associations bet

98 Minimally invasive colectomy (MIC) is an increasingly common surgical procedure.

99 lphide isomerase DsbA increases the colistin MIC of laboratory E. coli.

100 Zinc deprivation reduces colistin MICs in MCR-1-producing laboratory, environmental, anima

101 d by combining microwave-induced combustion (MIC) and inductively coupled plasma mass spectrometry (I

102 ated combining microwave-induced combustion (MIC) digestion with inductively coupled plasma mass spec

103 recent years, microwave-induced combustion (MIC) has proved to be a robust sample preparation techni

104 50 to 92%) by microwave-induced combustion (MIC) is proposed for the first time for further halogens

105 eftriaxone minimum inhibitory concentration (MIC) >/=0.06 mg/L and azithromycin MIC >/=0.5 mg/L, of w

106 ents had a minimum inhibitory concentration (MIC) >2 mug/mL to penicillin.

107 gents [VRE minimum inhibitory concentration (MIC) = 0.01-0.005 mug/mL] with activity that can be attr

108 d, and the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) were est

109 suring the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC).

110 e IC50 and minimal inhibitory concentration (MIC) are dubious proxies for understanding how evolution

111 wering the minimum inhibitory concentration (MIC) by more than one order of magnitude against both se

112 ase in the minimal inhibitory concentration (MIC) for the hybrid, while moxifloxacin or tobramycin re

113 ent with a minimal inhibitory concentration (MIC) of 12.5 mug/mL and an Mtb Ag85C apparent IC50 of 8.

114 ound had a minimum inhibitory concentration (MIC) of 52 nM and was not cytotoxic against eukaryotic c

115 The minimum inhibitory concentration (MIC) of an antimicrobial drug for a bacterial pathogen i

116 AUC0-24 to minimum inhibitory concentration (MIC) ratio (r(2) = 0.98).

117 excellent minimum inhibitory concentration (MIC) values against non-albicans Candida and Aspergillus

118 covers the minimum inhibitory concentration (MIC) values of the most commonly encountered uropathogen

119 daptomycin minimum inhibitory concentration (MIC) was 4 mg/L in 78 (69.6%) and </=2 mg/L in 34 (30.4%

120 The minimum inhibitory concentration (MIC) was much lower for Gram positive bacteria (Enteroco

121 peptide's minimum inhibitory concentration (MIC), but rather its ability to generate negative Gaussi

122 ithromycin minimum inhibitory concentration (MIC).

123 ithromycin minimum inhibitory concentration (MIC).

124 was change in myocardial iron concentration (MIC) determined by magnetic resonance imaging at 12 mont

125 points of minimum inhibitory concentrations (MIC) of Plantae, Bacteria, and Fungi exposed to As, Cd,

126 on of the minimal inhibitory concentrations (MIC) quantified the potency of the in situ click product

127 meropenem minimum inhibitory concentrations (MICs) >/=16 microg/mL, while non-CP-CRE isolates were mo

128 thromycin minimum inhibitory concentrations (MICs) >256 mug/mL and elevated ceftriaxone MICs (>/=0.12

129 that the minimum inhibitory concentrations (MICs) against fluoroquinolones have risen significantly

130 formed at minimum inhibitory concentrations (MICs) in all planktonic strains.

131 aptomycin minimum inhibitory concentrations (MICs) in the higher end of susceptibility frequently har

132 The minimal inhibitory concentrations (MICs) of four antimicrobial agents, namely, cefazolin, c

133 lls), the minimum inhibitory concentrations (MICs) of imipenem against clinical isolates of Escherici

134 Minimum inhibitory concentrations (MICs) were determined on baseline isolates.

135 n and the minimum inhibitory concentrations (MICs) were determined.

136 ntibiotic minimum inhibitory concentrations (MICs).

137 e VET01-S2 (disk and MIC) and M100-S25 CoNS (MIC) breakpoints agreed with the results of mecA/mecC PC

138 cally evoked maximal-intensity contractions (MICs) on protein phosphorylation in mouse skeletal muscl

139 cally evoked maximal-intensity contractions (MICs).

140 Prevention of microbially induced corrosion (MIC) is of great significance in many environmental appl

141 Microbiologically Influenced Corrosion (MIC) is a serious problem in many industries because it

142 g to microbiologically influenced corrosion (MIC).

143 the use of Microfluidic Impedance Cytometry (MIC) to characterise the AC electrical (impedance) prope

144 laboratory performed standardized daptomycin MIC testing for all isolates.

145 in mortality with respect to the daptomycin MIC.

146 Daptomycin MICs of 3-4 microg/mL in the initial E. faecium blood is

147 cted with isolates that exhibited daptomycin MICs of 3-4 microg/mL.

148 al outcomes than those exhibiting daptomycin MICs </=2 microg/mL.

149 s with E. faecium BSIs exhibiting daptomycin MICs of 3-4 microg/mL treated with daptomycin are more l

150 ariate logistic regression model, daptomycin MICs of 3-4 microg/mL (odds ratio [OR], 4.7 [1.37-16.12]

151 he qualitative FAST results and FAST-derived MIC (MICFAST) correspond closely with broth microdilutio

152 ance readings and data analysis to determine MICs.

153 For the agar dilution MIC, a 4-dilution QC range (0.015 to 0.12 mug/ml) center

154 2 mug/ml for the 7H10 and 7H11 agar dilution MICs and 0.015 to 0.06 mug/ml for the 7H9 broth microdil

155 utation effects and interactions on the drug MICs.

156 ause only subtle increases in the MIC, i.e., MICs ranging from 0.12 to 0.25 mg/liter for ciprofloxaci

157 o to the azole antifungals, but had elevated MICs with caspofungin.

158 llows the treatment of strains with elevated MICs that were formerly classified in the intermediate r

159 eurella multocida isolates with enrofloxacin MIC of 0.01 mug/mL, 1.5 mug/mL, and 2.0 mug/mL were used

160 tly less toxicity toward human erythrocytes (MIC = 1-4 mug/mL and HC50 = 805-1242 mug/mL).

161 ed an approximation algorithm for estimating MIC(X1; X2; Y) where Y is a discrete variable.

162 The best compounds obtained exhibited MIC values in the low micromolar range, excellent intrac

163 uginosa, we show here clinically-exploitable MICs on a non-negligible proportion of CF isolates, expl

164 For MIC, the rates of complications varied from 8.8% to 25.9

165 in rank from 6 of 97 for OC to 89 of 97 for MIC.

166 iate logistic regression after adjusting for MIC.

167 nezolid were tested as comparator agents for MIC and DD methods, respectively.

168 To assess rates of complications for MIC compared with OC among surgeons.

169 complications was nearly twice as great for MIC than for OC among surgeons enrolled in a statewide q

170 s, and surgeon rank by complication rate for MIC vs OC.

171 An extension from MIC(X; Y) to MIC(X1; X2; Y) is therefore desired.

172 moniae For all other variations, gepotidacin MIC and disk results were considered comparable to refer

173 d of a MIC-->U sigma-component and a U(5f)-->MIC(2p) pi-back-bond, but for the d(0) f(0) Y and La and

174 29% of the isolates had MICs </= 16 mg/L (proposed clinical breakpoint for temoc

175 ulence of R. oryzae RESULTS: All statins had MICs of >64 microg/mL against R. oryzae Exposure of R. o

176 m one laboratory were excluded due to higher MIC values than other laboratories.

177 al, the strains of S. radiatum showed higher MICs than S. commune.

178 respectively, were susceptible to imipenem (MIC, </=1 mug/ml).

179 o-treated in a panel of metal(II) cations in MIC assays.

180 ipine (n = 15) had a significant decrease in MIC compared with patients receiving placebo (n = 15) wi

181 acting N. gonorrhoeae induces an increase in MIC and may result in resistance.

182 atpE mutant exhibited a 50-fold increase in MIC for BDQ.

183 acting N. gonorrhoeae induces an increase in MIC, and may result in resistance.

184 n resulted in a 16- and 512-fold increase in MIC.

185 By contrast, nucleosomes in MIC are dramatically delocalized.

186 Agreement in MICs obtained by Etest was determined for fluconazole (2

187 ciated with modest 2- to 8-fold increases in MICs for BDQ and clofazimine, whereas one atpE mutant ex

188 ration was the only variable that influenced MICs; therefore, 50 mug/ml (standard for lipopeptide tes

189 e (CAZ) against resistant clinical isolates (MIC reduction, 32-fold).

190 tion, all ertapenem-nonsusceptible isolates (MIC, >/=1 mug/ml; n = 3,428) and 9,371 isolates of Esche

191 ads to the identification of many well-known MIC-regulated signalling pathways, as well as to a pleth

192 tedizolid MICs of </=1 mug/ml and linezolid MICs of </=4 mug/ml.

193 th the imidazole-CH2- series (7) showing low MIC values (6.25-25 mug/mL), which was also influenced b

194 effect, varied between the isolate with low MIC and less susceptible isolates.

195 enrofloxacin PD against the isolate with low MIC exhibited the expected concentration-dependent chara

196 tly missed because many isolates display low MICs for carbapenems.

197 The triazoles and terbinafine exhibited low MICs against all Exophiala isolates in vitro MALDI-TOF M

198 isolates were more likely to have meropenem MICs </=1 microg/mL (P value < .001).

199 correspond closely with broth microdilution MIC (MICBMD, Matthew's correlation coefficient 0.887), a

200 s, with a convenient 7H9 broth microdilution MIC method suitable for use in resource-limited settings

201 tuberculosis using a 7H9 broth microdilution MIC method.

202 ceptibility results from broth microdilution MIC testing of 993 Staphylococcus lugdunensis isolates r

203 For the 7H9 broth microdilution MIC, a 3-dilution QC range (0.015 to 0.06 mug/ml) center

204 0.06 mug/ml for the 7H9 broth microdilution MIC.

205 d to be PB resistant by broth microdilution (MIC > 2 mug/ml), including all 7 JMI isolates.

206 macronuclei (MAC) and germline micronuclei (MIC).

207 scriptionally silent germ-line micronucleus (MIC).

208 esting systems, the Vitek2 and the MicroScan MIC panel, to challenge the BacterioScan FLLS.

209 er, the half maximal (IC50) and the minimal (MIC) inhibitory concentrations.

210 y against C. neoformans (IC50 = 0.35 mug/mL, MIC = MFC = 0.63 mug/mL) with a selectivity index of >28

211 ts were outside +/-1 dilution from the modal MIC, suggesting enhanced reproducibility.

212 quantified their ofloxacin and moxifloxacin MIC by testing growth at six concentrations for each dru

213 r above the normal human threshold of 35 ms (MIC, 0.59 mg/g dry weight).

214 tor tubes (MGIT), and TREK Sensititre MycoTB MIC plate (MycoTB) methods.

215 Nafithromycin MIC QC ranges were determined to be 0.06 to 0.25 mug/ml

216 tion was not found when looking at natamycin MICs of baseline cultures after controlling for the infe

217 pathways, as well as to a plethora of novel MIC-regulated events.

218 The reproducibility and accuracy of MIC determinations were statistically equivalent to BMD.

219 a need for improved training in adoption of MIC techniques among some surgeons.

220 They are based on a combination of MIC values, pharmacokinetic/pharmacodynamic values, and

221 periment successfully identified a number of MIC-regulated phosphorylation events, a large proportion

222 his study) against the reference standard of MIC determinations.

223 his study) against the reference standard of MIC determinations.

224 ering the generally negligible pi-acidity of MICs, this is surprising and highlights that greater con

225 azole (0.60), and the Pearson correlation of MICs was strongest for fluconazole (0.94) and caspofungi

226 The evaluation of MICs and MBCs on 11 promysalin analogs, synthesized util

227 g of the molecular and cellular hallmarks of MICs will facilitate the development and deployment of n

228 According to the interpretation of MICs, 49% (n = 98) of the isolates were carbapenem resis

229 for doxycycline, respectively, and rates of MICs of </=2 mug/ml were 46.7% and 23.4% for tigecycline

230 0) f(0) Y and La and 4f(3) Nd congeners only MIC-->M sigma-bonding is found.

231 aboratories should perform oxacillin disk or MIC tests of these isolates when they are encountered.

232 ase-negative Staphylococcus (CoNS) oxacillin MIC breakpoint and cefoxitin disk breakpoint, the CLSI V

233 aureus/Staphylococcus lugdunensis oxacillin MIC breakpoints and cefoxitin disk and MIC breakpoints,

234 utomated susceptibility test panel oxacillin MIC results were also evaluated and demonstrated >95% ca

235 CLSI VET01-S2 S. pseudintermedius oxacillin MIC and disk breakpoints, and the European Committee on

236 elected to assess the accuracy of penicillin MIC testing, the penicillin disk diffusion test, and thr

237 The penicillin MIC test had 100% categorical agreement with blaZ PCR, w

238 outcomes for those same surgeons performing MIC.

239 ch constitutes a new, general way to prepare MIC complexes.

240 -susceptible classification and quantitative MIC measurement in a single process completed shortly af

241 tion should possibly be given to recognizing MICs as potential pi-acid ligands when coordinated to st

242 ty testing (DST) methodologies and reference MIC quality control (QC) ranges for bedaquiline, a diary

243 Our objective was to establish reference MIC quality control (QC) ranges for drug susceptibility

244 to and four-fold less than their respective MICs.

245 s excellent activity against drug-sensitive (MIC = 0.012 muM; SI >/= 16000), multidrug-resistant (MDR

246 Specifically, MIC was used to identify live and inactive C. parvum ooc

247 olates and one susceptible reference strain (MIC <1.5 mug/mul).

248 e evaluated for their effects on surotomycin MICs.

249 -tazobactam QC ranges for a fixed tazobactam MIC of 8 mug/ml and disk diffusion (30/20-mug disk) test

250 ess commonly isolated species, had tedizolid MICs of </=1 mug/ml and linezolid MICs of </=4 mug/ml.

251 cific porins expression decreased temocillin MIC by 1 two-fold dilution only.

252 exA or mexB in isolates for which temocillin MIC was </=512 mg/L (nucleotide insertions or deletions,

253 correlation was observed between temocillin MICs and efflux rate of N-phenyl-1-naphthylamine (MexAB-

254 ies 2-day biofilms were two-fold higher than MICs of cells shed from biofilms.

255 The results indicate that MIC(X1; X2; Y) also has the property of generality.

256 The MIC data were available for 221 of 323 participants (68.

257 The MIC endpoint should be 80% inhibition compared with the

258 The MIC of phenolic acid-rich extracts (24-49mugphenolics/mL

259 The MIC results measured by dAST were in good agreement with

260 time that concentrations persisted above the MIC (%TMIC).

261 tions for all antibiotics remained above the MIC for the susceptible organisms at 12 h.

262 ndards and Technology (NIST) has applied the MIC methodology in combination with isotope dilution ana

263 analogue 9 and 16 at 4 mug/mL decreased the MIC of rifampicin and clarithromycin against the same pa

264 microdilution techniques, we determined the MIC values of the anthelmintics against 16 C. difficile

265 In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most impor

266 ciliates, DNA from precursor segments in the MIC genome rearranges to form transcriptionally active g

267 33.8%] in the OC group vs 447 [14.3%] in the MIC group; P < .001).

268 mutations cause only subtle increases in the MIC, i.e., MICs ranging from 0.12 to 0.25 mg/liter for c

269 atory Standards Institute (CLSI) lowered the MIC breakpoints for many beta-lactam antibiotics to enha

270 provides the first comprehensive map of the MIC-regulated phosphoproteome.

271 meters rather than a single parameter of the MIC.

272 In this study, the MIC behavior of 2707 HDSS caused by the marine aerobe Ps

273 ase-substrate predictions indicated that the MIC-regulated phosphorylation sites were chiefly modifie

274 e limits of detection for Br and I using the MIC method followed by ICP-MS determination were 0.039 a

275 Using the MIC method, 350mg of whole egg powder and its fractions

276 ughout the study period (2005-2014), and the MICs against azithromycin declined, confirming the utili

277 Their MIC and MFC values indicated that the 2,3-unsaturated an

278 zae to statins at concentrations below their MICs decreased virulence both in vitro and in vivo.

279 fy resistant bacteria and characterize their MICs and resistance mechanisms to support extended simul

280 cline, and 92.5% of isolates had tigecycline MICs of </=2 mug/ml.

281 Localized corrosion of pipelines due to MIC is one of the key failure mechanisms of buried steel

282 that 2707 HDSS was not completely immune to MIC by the P. aeruginosa biofilm.

283 However, its resistance to MIC was not experimentally proven.

284 ative inner colony mutants were subjected to MIC testing, whole-genome sequencing, reverse transcript

285 An extension from MIC(X; Y) to MIC(X1; X2; Y) is therefore desired.

286 ibacterial activity against M. tuberculosis (MIC = 3.13 muM).

287 for ciprofloxacin (just above the wild-type MIC of </=0.06 mg/liter).

288 We analyzed 5196 patients who underwent MIC or OC from January 1, 2012, through December 31, 201

289 K 293T/17 within the range of their in vitro MICs and MBCs.

290 (95% CI, 1.13-4.56; P = .02) in voriconazole MICs after controlling for the infectious organism was f

291 erial activities against MRSA, MRSE and VRE (MIC = 0.003-0.78 microM).

292 ungal activity against Candida albicans with MIC of 15.6mug/mL.

293 , and 36 were the most potent analogues with MIC values as low as 0.39 mug/mL.

294 activity against Klebsiella planticola with MIC of 15.6mug/mL and compound 1-(4-hydroxy-3-methoxy) b

295 azide), was active against MRSA and VRE with MIC's of 8.1 and 4.7 muM, respectively.

296 n-resistant Enterococcus faecium (VREF) with MIC values of 1.4 and 2.2 mug mL(-1), respectively.

297 ad range of bacteria, relative to OV-3, with MICs as low as 1.3 +/- 0.6 muM.

298 hibited promising inhibitory activities with MICs ranging 1-8 mug/mL against MRSA strains.

299 lates (18%) comprising three sequevars, with MICs of </=2 (80%), 4 (10%), and 8 (10%) mug/ml.

300 nd to be the most active of the series, with MICs in the range of 0.5-4 mug/mL against the MDR Staphy

301 against the MDR Gram-negative strains, with MICs in the range of 16-32 mug/mL.

302 hylococcus aureus and Bacillus subtilis with MICs ranging from 5.5 to 17 muM.